Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -2.28% is 107% below its 5-year average of 32.27%, around the middle of its 5-year range (-27.33%–52.84%).
As of the fiscal period ended Tuesday, March 31, 2026. 105.79% below its 12-month average of 39.43%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
-2.28%
EBITDA MARGIN AVG TTM
39.43%
EBITDA MARGIN AVG 3Y
43.00%
EBITDA MARGIN AVG 5Y
39.58%
EBITDA MARGIN AVG 10Y
37.01%
EBITDA MARGIN AVG 15Y
35.06%
EBITDA MARGIN AVG 20Y
34.05%
CURRENT VS TTM AVG
-105.79%
CURRENT VS 3Y AVG
-105.31%
CURRENT VS 5Y AVG
-105.77%
CURRENT VS 10Y AVG
-106.17%
CURRENT VS 15Y AVG
-106.52%
CURRENT VS 20Y AVG
-106.71%
Merck & Co., Inc.
Market Cap
$323.72B
EBITDA Margin
-2.28%
TTM Avg
39.43%
3Y Avg
43.00%
5Y Avg
39.58%
Market Cap
$382.09B
EBITDA Margin
5.21%
TTM Avg
7.15%
3Y Avg
8.47%
5Y Avg
8.86%
Market Cap
$211.18B
EBITDA Margin
24.44%
TTM Avg
24.78%
3Y Avg
25.35%
5Y Avg
27.67%
Market Cap
$179.58B
EBITDA Margin
24.35%
TTM Avg
24.15%
3Y Avg
24.77%
5Y Avg
25.59%
Market Cap
$160.55B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | $323.72B | -2.28% | 39.43% | 43.00% | 39.58% |
| UnitedHealth Group Incorporated (UNH)vs › | $382.09B | 5.21% | 7.15% | 8.47% | 8.86% |
| AstraZeneca PLC (AZN)vs › | $262.31B | 33.16% | 30.52% | 27.50% | 25.68% |
| Novo Nordisk A/S (NVO)vs › | $216.72B | 48.42% | 49.59% | 48.46% | 47.82% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $211.18B | 24.44% | 24.78% | 25.35% | 27.67% |
| Amgen Inc. (AMGN)vs › | $202.95B | 43.12% | 40.78% | 43.34% | 44.32% |
| AbbVie Inc. (ABBV)vs › | $458.11B | 46.16% | 38.63% | 40.64% | 41.43% |
| Abbott Laboratories (ABT)vs › | $179.58B | 24.35% | 24.15% | 24.77% | 25.59% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 49.12% | 32.26% | 34.27% | 33.90% |
| Pfizer Inc. (PFE)vs › | $139.86B | 32.51% | 34.72% | 32.84% | 32.73% |
Gross Margin
75.9%
EBITDA Margin
-2.3%
Operating Margin
36.2%
Net Margin
13.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | -2.28% |
| 2025-12-31 | 52.84% |
| 2025-09-30 | 49.67% |
| 2025-06-30 | 46.93% |
| 2025-03-31 | 50.00% |
| 2024-12-31 | 35.49% |
| 2024-09-30 | 31.04% |
| 2024-06-30 | 45.06% |
| 2024-03-31 | 42.75% |
| 2023-12-31 | -5.12% |
| 2023-09-30 | 43.14% |
| 2023-06-30 | -27.33% |
| 2023-03-31 | 33.11% |
| 2022-12-31 | 31.66% |
| 2022-09-30 | 33.86% |
| 2022-06-30 | 41.15% |
| 2022-03-31 | 42.40% |
| 2021-12-31 | 33.90% |
| 2021-09-30 | 43.20% |
| 2021-06-30 | 21.26% |
| 2021-03-31 | 35.01% |
| 2020-12-31 | -8.28% |
| 2020-09-30 | 30.32% |
| 2020-06-30 | 36.47% |
| 2020-03-31 | 39.83% |
| 2019-12-31 | 31.16% |
| 2019-09-30 | 27.90% |
| 2019-06-30 | 37.68% |
| 2019-03-31 | 39.81% |
| 2018-12-31 | 35.89% |
| 2018-09-30 | 34.82% |
| 2018-06-30 | 33.98% |
| 2018-03-31 | 22.78% |
| 2017-12-31 | 31.58% |
| 2017-09-30 | 12.59% |
| 2017-06-30 | 37.20% |
| 2017-03-31 | 34.73% |
| 2016-12-31 | 6.88% |
| 2016-09-30 | 40.29% |
| 2016-06-30 | 32.58% |
| 2016-03-31 | 35.70% |
| 2015-12-31 | 34.38% |
| 2015-09-30 | 38.82% |
| 2015-06-30 | 34.18% |
| 2015-03-31 | 33.47% |
| 2014-12-31 | 29.56% |
| 2014-09-30 | 31.36% |
| 2014-06-30 | 28.87% |
| 2014-03-31 | 37.09% |
| 2013-12-31 | 34.01% |
| 2013-09-30 | 37.80% |
| 2013-06-30 | 28.52% |
| 2013-03-31 | 32.72% |
| 2012-12-31 | 30.88% |
| 2012-09-30 | 35.63% |
| 2012-06-30 | 37.28% |
| 2012-03-31 | 38.77% |
| 2011-12-31 | 31.36% |
| 2011-09-30 | 35.59% |
| 2011-06-30 | 35.33% |
| 2011-03-31 | 34.80% |
| 2010-12-31 | 11.78% |
| 2010-09-30 | 29.66% |
| 2010-06-30 | 29.89% |
| 2010-03-31 | 22.94% |
| 2009-12-31 | 10.06% |
| 2009-09-30 | 33.61% |
| 2009-06-30 | 32.38% |
| 2009-03-31 | 30.41% |
| 2008-12-31 | 29.64% |
| 2008-09-30 | 32.90% |
| 2008-06-30 | 31.90% |
| 2008-03-31 | 35.08% |
| 2007-12-31 | 33.57% |
| 2007-09-30 | 27.22% |
| 2007-06-30 | 31.83% |
| 2007-03-31 | 33.14% |
| 2006-12-31 | 14.05% |
| 2006-09-30 | 20.58% |
| 2006-06-30 | 33.94% |
| 2006-03-31 | 37.59% |
| 2005-12-31 | 28.36% |
| 2005-09-30 | 35.39% |
| 2005-06-30 | 36.65% |
| 2005-03-31 | 37.64% |
| 2004-12-31 | 24.17% |
| 2004-09-30 | 33.45% |
| 2004-06-30 | 43.31% |
| 2004-03-31 | 39.48% |
| 2003-12-31 | 35.43% |
| 2003-09-30 | 47.99% |
| 2003-06-30 | 44.60% |
| 2003-03-31 | 44.18% |
| 2002-12-31 | 21.77% |
| 2002-09-30 | 46.72% |
| 2002-06-30 | 21.25% |
